Corvus Pharmaceuticals Inc Long-term Investment Intensity
Corvus Pharmaceuticals Inc long-term investment intensity. Corvus Pharmaceuticals Inc (CRVS) has a Long-term Investment Intensity of 6.3% as of June 2026. Long-term investments of $15.11 Million represent 6.3% of total assets of $239.27 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Corvus Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Corvus Pharmaceuticals Inc (2020–2025)
Long-term investment intensity of Corvus Pharmaceuticals Inc from 2020 to 2025. This chart shows how Corvus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the intensity stands at 6.3%, reflecting long-term investments of $15.11 Million against total assets of $239.27 Million USD.
Corvus Pharmaceuticals Inc Long-term Investment Intensity by Year (2020–2025)
Corvus Pharmaceuticals Inc long-term investment intensity by year from 2020 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Corvus Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Corvus Pharmaceuticals Inc's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 15.5% | $10.99 Million | $71.12 Million | ▼ -2.7 pp |
| 2024 | 18.2% | $12.54 Million | $68.91 Million | ▼ -17.2 pp |
| 2023 | 35.4% | $16.12 Million | $45.55 Million | ▲ +3.3 pp |
| 2022 | 32.1% | $21.88 Million | $68.24 Million | ▲ +0.8 pp |
| 2021 | 31.3% | $34.27 Million | $109.45 Million | ▼ -12.2 pp |
| 2020 | 43.5% | $37.23 Million | $85.53 Million | — |